Exane Derivatives’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $149K | Buy |
1,271
+454
| +56% | +$53.4K | 0.09% | 209 |
|
|
2022
Q1 | $106K | Hold |
817
| – | – | 0.03% | 466 |
|
|
2021
Q4 | $125K | Sell |
817
-20
| -2% | -$3.05K | 0.03% | 412 |
|
|
2021
Q3 | $135K | Buy |
837
+60
| +8% | +$9.7K | 0.03% | 474 |
|
|
2021
Q2 | $125K | Hold |
777
| – | – | 0.03% | 504 |
|
|
2021
Q1 | $117K | Sell |
777
-48
| -6% | -$7.23K | 0.03% | 392 |
|
|
2020
Q4 | $125K | Sell |
825
-176
| -18% | -$26.7K | 0.04% | 361 |
|
|
2020
Q3 | $136K | Buy |
1,001
+940
| +1,541% | +$127K | 0.04% | 235 |
|
|
2020
Q2 | $8.34K | Hold |
61
| – | – | ﹤0.01% | 405 |
|
|
2020
Q1 | $6.57K | Sell |
61
-2,169
| -97% | -$234K | ﹤0.01% | 418 |
|
|
2019
Q4 | $271K | Hold |
2,230
| – | – | 0.05% | 209 |
|
|
2019
Q3 | $222K | Hold |
2,230
| – | – | 0.04% | 227 |
|
|
2019
Q2 | $243K | Hold |
2,230
| – | – | 0.04% | 230 |
|
|
2019
Q1 | $249K | Hold |
2,230
| – | – | 0.05% | 189 |
|
|
2018
Q4 | $215K | Sell |
2,230
-1
| -0% | -$96 | 0.04% | 211 |
|
|
2018
Q3 | $272K | Hold |
2,231
| – | – | 0.05% | 212 |
|
|
2018
Q2 | $245K | Buy |
2,231
+2,230
| +223,000% | +$245K | 0.04% | 222 |
|
|
2018
Q1 | $106 | Sell |
1
-455
| -100% | -$48.2K | ﹤0.01% | 518 |
|
|
2017
Q4 | $48.7K | Buy |
456
+90
| +25% | +$9.61K | 0.01% | 304 |
|
|
2017
Q3 | $40.7K | Sell |
366
-33
| -8% | -$3.67K | 0.01% | 293 |
|
|
2017
Q2 | $41.2K | Sell |
399
-330
| -45% | -$34.1K | 0.01% | 293 |
|
|
2017
Q1 | $71.3K | Buy |
729
+174
| +31% | +$17K | 0.02% | 229 |
|
|
2016
Q4 | $49.1K | Sell |
555
-429
| -44% | -$37.9K | 0.01% | 271 |
|
|
2016
Q3 | $94.9K | Sell |
984
-2,637
| -73% | -$254K | 0.01% | 219 |
|
|
2016
Q2 | $309K | Buy |
+3,621
| New | +$309K | 0.05% | 172 |
|